Desmethyl Macrolides: Synthesis and Evaluation of 4,8-Didesmethyl Telithromycin
Overview
Authors
Affiliations
There is an urgent need for novel sources of antibiotics to address the incessant and inevitable onset of bacterial resistance. To this end, we have initiated a structure-based drug design program that features a desmethylation strategy (i.e., replacing methyl groups with hydrogens). Herein we report the total synthesis, molecular modeling and biological evaluation of 4,8-didesmethyl telithromycin (), a novel desmethyl analogue of the third-generation ketolide antibiotic telithromycin (), which is an FDA-approved semisynthetic derivative of erythromycin (). We found 4,8-didesmethyl telithromycin () to be more active than previously prepared 4,8,10-tridesmethyl congener () and more active than 4,10-didesmethyl regioisomer () in MIC assays. While less potent than telithromycin () and paralleling the observations made in the previous study of 4,10-didesmethyl analogue (), the inclusion of a single methyl group improves biological activity thus supporting its role in antibiotic activity.
Daher S, Lee M, Jin X, Teijaro C, Barnett P, Freundlich J Eur J Med Chem. 2022; 233:114213.
PMID: 35240514 PMC: 9009214. DOI: 10.1016/j.ejmech.2022.114213.
Daher S, Lee M, Jin X, Teijaro C, Wheeler S, Jacobson M ChemMedChem. 2021; 16(21):3368-3373.
PMID: 34355515 PMC: 8571068. DOI: 10.1002/cmdc.202100435.
Natural Products as Platforms To Overcome Antibiotic Resistance.
Rossiter S, Fletcher M, Wuest W Chem Rev. 2017; 117(19):12415-12474.
PMID: 28953368 PMC: 5869711. DOI: 10.1021/acs.chemrev.7b00283.
Desmethyl macrolides: synthesis and evaluation of 4-desmethyl telithromycin.
Glassford I, Lee M, Wagh B, Velvadapu V, Paul T, Sandelin G ACS Med Chem Lett. 2014; 5(9):1021-6.
PMID: 25221660 PMC: 4160760. DOI: 10.1021/ml5002097.
The evolving role of chemical synthesis in antibacterial drug discovery.
Wright P, Seiple I, Myers A Angew Chem Int Ed Engl. 2014; 53(34):8840-69.
PMID: 24990531 PMC: 4536949. DOI: 10.1002/anie.201310843.